Integrating AI Into Market Access Workflows

Description AI is no longer a future concept—it is becoming embedded in the daily operations of pharmaceutical Market Access teams. This panel brings together experts from across the industry to explore how AI is starting to reshape core workflows, from developing value dossiers and pricing strategies to managing stakeholder insights and health economic evidence. Rather than focusing on specific tools or products, this discussion aims to provide a general, cross-functional view on the current and near-future use of AI in Market Access. We will explore practical examples, organizational hurdles, regulatory considerations, and how teams are adapting skill sets and mindsets. The panel will share lessons learned, best practices, and predictions for how AI will continue to shape the field. The session is ideal for professionals working in Market Access, Health Economics, and related functions who want to understand how AI is being used beyond theory—and how to prepare their teams and organizations for this transformation. Summary A cross-industry panel exploring how AI is being integrated into the daily workflows of Market Access teams. The session covers real-world applications, organizational change, and the evolving role of AI in shaping access strategies and value communication. Learning objectives Understand current AI use cases in Market Access teams Identify key opportunities and challenges in adopting AI for daily workflows Learn how to prepare teams and skill sets for an AI-driven future Gain insight into the regulatory and ethical considerations around AI in access-related functions